Studies of the pattern of cancer incidence or mortality among migrant populations are a useful tool for exploring the aetiology of cancer, especially with regard to the possible role of genetic, lifestyle, and environmental factors.'2 These studies have generally compared the occurrence of the disease in migrants from very different cultural or even ethnic backgroundsfor instance, Japanese migrants to the USA3 and Brazil,4 or Italian migrants in other countries.5 Different patterns of mortality or incidence are found in these studies in cancers of the stomach, breast, cervix, colon-rectum, and others. Few of these studies, however, have analysed differences in cancer risk in those who migrate within one country. [6] [7] [8] [9] Cervical cancer shows an important international variation in its incidence. ' The population based cancer registry of Girona is restricted to cancer of the breast, uterus, ovary, and other genitals. It actively collects information on all incident cases among the residents in the province of Girona. Quality indices regarding cervical cancer were as follows: 98 3% of histological verification and 1% of cases were identified by death certificate only. Cancer cases are classified according to the ICD-O (9th revision). The cancer registry provided information on the patient's age, tumour site, stage of the disease (divided into local, regional and disseminated), and follow up status. The registry includes cases since January 1980: all cases were followed up actively and passively (through death certificates) until December 1991. Cancers in situ were included in the registry, but only presented for descriptive purposes. Place of birth is routinely collected, and has been used to identify first generation migrants. The year of migration is not available.
Rates were initially calculated by grouping the cases into two periods 1980-84 and 1985-Borras, Sdnchez, Moreno, Izquierdo, Viladiu 89. The results were highly consistent, and results for the entire period (1980-89) are therefore presented. Age adjustment of the rates was performed by the direct method and using the world standard population. Migrants were classified according to region of birth as follows: born in Girona and in other parts of Catalonia, born in the south of Spain (including Andalusia and Extremadura), born in other regions of Spain, and born in other countries.
Comparison of the age standardised incidence rates was done using the standardised rate ratio (SRR) and 95% confidence interval (95% CI).'7 SRR is the ratio between two directly age adjusted rates and is equivalent to the relative risk of disease in migrant population compared to local born population.
It is possible to calculate the statistical significance ofthe SRR as an indication ofwhether the observed ratio is significantly different from unity.
Differences in the stage at diagnosis according to region of birth were analysed by the x statistic. Survival was analysed first by region of birth, using the Kaplan-Meier estimate. To compare the probabilities of survival according to the region of birth, the log rank test was used. To adjust for differences in the stage at diagnosis or age on the relationship between region of birth and survival, Cox's proportional hazard model was used.'8 The following variables were included in the model: age at diagnosis, region of birth, and stage at diagnosis. Age was divided into the following groups: less than 34, 34-45, 45-54, 55-64, and 65 and over. The reference categories used for the analysis were as follows: age group was less than 35 years, stage at diagnosis local, and Ascertainment of cases through histological verification and coverage of the registry with regard to cervical cancer are comparable with other registries.'013 It should be noted that in 8-6% of cases it was not possible to ascertain the region of birth. The true distribution of place ofbirth in cases with an unknown place of birth tends to over-represent migrant patients, who are more likely to escape information retrieval procedures; in this case our findings of a twofold higher incidence among migrants should be viewed as an underestimation of the true incidence excess. If, in contrast, the cases of unknown place of birth were all local born, the analysis presented in tables 1 and 2 would still show a statistically significant excess among migrants. In our study, it was not possible to control for the length of stay in Girona or the age at migration. The former is an important variable in migrant studies,22' the latter is relevant in cervical cancer because of the established association with age at first intercourse and number of sexual partners, two variables likely to differ in relation to social class and place of residence.
The higher incidence of invasive cervical cancer among migrant women in Girona could be accounted for by two complementary factors: differential exposure to risk factors for cervical cancer and differential participation rate in screening activities. With regard to the first factor, the higher incidence could be partly explained by low socioeconomic status or lifestyles specific to migrant populations. Migrants are usually young people, and this population has shown different nuptial and fecundity rates but these rates are not independent of age in our It is probable that socioeconomic differences are related to an increased risk of cervical cancer.
The second suggested explanation for these results is the lower rate of participation in cervical cancer screening. Screening for cervical cancer effectively reduces the incidence among those who participate for at least 10 years after a negative test.30 Screening is not centrally organised in Catalonia, it is a byproduct of gynaecological health care, largely private, and in many cases supported by social security. Data from a survey undertaken in the municipality of Girona and its surroundings3' indicate that the cervical cytology rate of migrants is lower than that of local born women (30 7% and 23-4% respectively) and a strong relationship between educational level and self reported cervical screening was observed. Other authors have suggested that women from lower socioeconomic groups are less likely to have a screening test.32 This is partly supported by the significant difference in the proportions of cancers "in situ" found in relation to the region of birth (table 3) . In fact, cancer in situ is largely a surrogate for screening practices. The possibility of uncompleted registration of in situ cancers makes any conclusion regarding these data provisional. The length of stay of the migrant population, a variable not available in our study, has been related to the observed reduction in the risk of invasive cancer in Israel,33 34 where the trend also differed in relation to the place of birth of the migrants. The suggested explanation for this observation lies on the cumulative exposure to cytological screening in migrants after arriving in Israel.
In conclusion, cytological screening could play a major role in explaining the difference in the incidence of invasive cervical cancer among migrants to Girona.
In this context, it is remarkable that differences in the cervical cancer incidence in relation to the region of birth do not suggest a difference in prognosis. This observation could indicate that the main problem of equity in health care detected in our study is one of accessibility to screening and not of the quality of treatment .35 This finding is consistent with other authors who have found little effect of socioeconomic differences on survival for this type of cancer,3637 and who pointed to equity of access to treatment as the main explanation for this finding.
Migrant studies are a useful tool for describing the epidemiology of a disease in a geographical area. Girona, like other regions of Spain, is an area with a low incidence of cervical cancer and one in which there is a twofold higher incidence rate in migrants than in native born women. The cancer stage at diagnosis is more advanced in migrants but survival is not significantly different in relation to the region of birth. The main reason for the higher incidence seems to lie in limited access to screening among migrants. It is possible that the differences observed in this first generation of migrants will disappear with time and in second generation migrants. Further research is needed to interpret fully these results. In particular, reasons for differences in the distribution of stage at diagnosis and access to screening practices should be addressed.
